Anti‐thrombin (AT, SERPINC1) has been investigated as a treatment for severe bacterial sepsis and DIC (Papageorgiou et al, 2018; Levi et al, 2020; Levi & Thachil, 2020). This evidence concerns the gene SERPINC1 and bacterial infectious disease with sepsis.